×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Athersys files for bankruptcy, sells assets to Healios in wake of stroke cell therapy's struggles
Fierce Biotech
With Athersys' days now numbered, Healios has swooped in and bought up all of the biotech's assets for $2 million via a credit bid.
3 months ago
Athersys Adds to Surge of Biotechs Filing for Bankruptcy, Sells to Healios
BioSpace
All assets of the regenerative medicine and cell therapy company are being divested to its research partner to the tune of $2 million in the...
3 months ago
Athersys (OTCPK:ATHX.Q) - Stock Price, News & Analysis
Simply Wall Street
Research Athersys' (OTCPK:ATHX.Q) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.
3 months ago
Athersys (NASDAQ:ATHX) Receives New Coverage from Analysts at StockNews.com
Defense World
Read Athersys (NASDAQ:ATHX) Receives New Coverage from Analysts at StockNews.com at Defense World.
5 days ago
Athersys filed for Chapter 11, plans to sell assets to Healios
Crain's Cleveland Business
Cell therapy and regenerative medicine company Athersys Inc. of Cleveland has filed for Chapter 11 bankruptcy protection and has signed an...
3 months ago
Athersys Finalizes Sale to HEALIOS Amidst Board Reorganization - TipRanks.com
Tipranks
Athersys (ATHXQ) just unveiled an announcement. In a significant move, the Debtors have successfully negotiated an asset sale to HEALIOS K.K.,...
4 weeks ago
Athersys bankruptcy filing could lead to sale of most assets to development partner
Cleveland.com
Athersys bankruptcy filing could lead to sale of most assets to development partner ... CLEVELAND, Ohio - Regenerative medicine developer Athersys...
3 months ago
Healios Acquires Bankrupt Athersys, Expands Cell Therapy R&D Programs
Scrip
Tokyo-based Healios will lead the global clinical studies for Athersys' cell therapy MultiStem for ARDS and start US Phase II trials for trauma following...
4 weeks ago
Athersys to Sell Most Assets to Healios
MarketWatch
By Adriano Marchese Athersys will sell virtually all of its assets to regenerative medicine and cell therapy company Healios in an agreement...
3 months ago
Athersys shares delisted by Nasdaq Stock Market
The Business Journals
Shares of Athersys ended trading Wednesday at about 10 cents and have not traded since.
6 months ago